Stockreport

Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance

Amarin Corporation plc - American Depositary Shares, each representing one Ordinary Share  (AMRN) 
Last amarin corporation plc - american depositary shares, each representing one ordinary share earnings: 4/30 05:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.amarincorp.com/investors
PDF Record Revenue Achieved in 1H19 Primarily Due to Increased Demand for VascepaGuidance for Total 2019 Revenue Increased to a Range of $380 to $420 Million from $350 Milli [Read more]